Novel epi-virotherapeutic treatment of pancreatic cancer combining the oral histone deacetylase inhibitor resminostat with oncolytic measles vaccine virus
Tim Patrick Ellerhoff(University of Tübingen), Ulrich M. Lauer(German Cancer Research Center)
Cited by 18
Related Papers
NUT Carcinoma—An Underdiagnosed Malignancy
|Frontiers in Oncology|2022|48
274 Comprehensive spatial immune profiling of pediatric NUT carcinoma identifies novel prognostic signatures and B7-H3 as a target for CAR-T cell therapy
|Regular and Young Investigator Award Abstracts|2025|0